Oncology July 2008

Oncology July 2008

Anticoagulation Management in Patients with Cancer

Cancer, chemotherapy, and surgery are conditions that increase the risk of the development of venous thromboembolism (VTE), a common and potentially life-threatening condition.

Cytogenetics of Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized by a translocation between chromosomes 9 and 22, forming the Philadelphia (Ph) chromosome.

Thalidomide: New Cancer Uses for an Old Drug

Thalidomide, a drug once thought to have no clinical benefit due to its significant toxicity, has now become a potential agent for the treatment of hematologic malignancies and some solid tumors.

Continuing Education

$7.95 Per CE Exam or $69 for 12 Lessons